BSE filing, NSE: WOCKPHARMA. Summary written from the filing by ALFA Finder's alert engine.
Wockhardt Ltd: key numbers
- Share price
- ₹1,913.40
- Market cap
- ₹31,091 Cr
- Revenue (annual)
- ₹3,373 Cr
- Net profit (annual)
- ₹213.0 Cr
- P/E (TTM)
- 76.0×Sector 46.1×
- Promoter holding
- 49.32%+0.24% QoQ
- FII holding
- 7.02%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Wockhardt Ltd
All →Wockhardt Board Meeting Date
Wockhardt Ltd intimated that its Board will meet on 2 Nov 2026 to approve Q1 FY27 unaudited results. The trading window remains closed until 48 hours post-declaration.
Wockhardt Other Announcement
The company submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31.
Wockhardt Legal & Regulatory
Wockhardt Limited received an order from the Commissioner of Customs imposing a ₹5 Crore penalty and ₹10 Crore redemption fine. The company plans to challenge this order.
- Value
- ₹15.00 Cr
Wockhardt Legal & Regulatory
Wockhardt Limited received an adjudication order from the Commissioner of Customs imposing penalties and redemption fines aggregating to ₹16 Crore regarding API mis-classification.
- Value
- ₹16.00 Cr
Wockhardt Other Announcement
Wockhardt Limited submitted the Monitoring Agency Report for the quarter ended June 30, 2026. The report confirms no deviation in the utilization of QIP proceeds.
Wockhardt Business Update
Wockhardt Limited launched the 'Wockhardt Antibiotic Academy,' an open scientific learning platform aimed at facilitating knowledge exchange to tackle multidrug resistance among healthcare professionals.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date